LIVER RESEARCH AND DEVELOPMENT LIMITED

Company number 07944232 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£10,027,783

Balance sheet as at 2024-06-30

View full accounts →

What it does

The company is the wholly owned subsidiary of The Foundation for Liver Research, and its principal activity is medical research into various causes of liver damage with a view to commercial collaborations and/or development.

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2012-02-09
Employees
21 (2024 accounts)
Registered office
111 Coldharbour Lane, London, England, SE5 9NT
Postcode
SE5 9NT
Capital
100 GBP
Accounts category
Small

Accounts

Last made up to
2025-06-30
Next due by
2027-03-31
Financial year end
30 June

Confirmation statement

Last statement dated
2026-03-22
Next due by
2027-04-05
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 5 current · 7 resigned

Appointed 2026-06-10
Anna BENNETT Director
Appointed 2024-11-01
Appointed 2023-11-17
Appointed 2022-10-05
Appointed 2012-02-09

View all officers and resignations →

Previous registered addresses 1

AddressChanged on
HAROLD SAMUEL HOUSE 69 - 75, CHENIES MEWS, LONDON, WC1E 6HX2017-10-26

Among its peers

Top 10%

by shareholders' funds, of 44 similar companies in SE

Among the biggest employers among its local peers (21 staff).

Among the oldest 25% of its local peers, trading since 2012.

No.3 of the largest research and experimental development on biotechnology companies in London →

Competitors London

This company ranks 3 among research and experimental development on biotechnology in London.

Full league table →

The class of 2012

32%

of the 280 companies in this sector incorporated in 2012 are still active today; 66% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →